Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buffet

Showing results (311-320 of 324) with videos related to

Pageof 33
Sort By:
Journal of Hepatology|April 16, 1998
Characteristics of patients with dual infection by hepatitis B and C virusesJ P Zarski, B Bohn, A Bastie, et al.
AIDS (London, England)|October 2, 2001
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide studyD Descamps, V Calvez, J Izopet, et al.
Journal of Clinical Microbiology|July 1, 1997
Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assayJ M Pawlotsky, L Prescott, P Simmonds, et al.
Journal of Endocrinological Investigation|April 5, 2024
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma statusL Schubert, A M Mbekwe-Yepnang, J Wassermann, et al.
Gut|February 22, 2014
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADNH Fontaine, S Kahi, C Chazallon, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitorsB Masquelier, E Race, C Tamalet, et al.
Antiviral Therapy|February 22, 2000
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over studyB Masquelier, D Descamps, I Carrière, et al.
Journal of Viral Hepatitis|December 22, 1999
A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 groupT Poynard, V Daurat, S Chevret, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
ESMO Open|March 4, 2026
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RETJ Hadoux, J Hernando, K H Wong, et al.
Pageof 33

Showing results (311-320 of 324) with videos related to

Sort By:
Pageof 33
Journal of Hepatology|April 16, 1998
Characteristics of patients with dual infection by hepatitis B and C virusesJ P Zarski, B Bohn, A Bastie, et al.
AIDS (London, England)|October 2, 2001
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide studyD Descamps, V Calvez, J Izopet, et al.
Journal of Clinical Microbiology|July 1, 1997
Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assayJ M Pawlotsky, L Prescott, P Simmonds, et al.
Journal of Endocrinological Investigation|April 5, 2024
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma statusL Schubert, A M Mbekwe-Yepnang, J Wassermann, et al.
Gut|February 22, 2014
Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADNH Fontaine, S Kahi, C Chazallon, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitorsB Masquelier, E Race, C Tamalet, et al.
Antiviral Therapy|February 22, 2000
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over studyB Masquelier, D Descamps, I Carrière, et al.
Journal of Viral Hepatitis|December 22, 1999
A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 groupT Poynard, V Daurat, S Chevret, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
ESMO Open|March 4, 2026
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RETJ Hadoux, J Hernando, K H Wong, et al.
Pageof 33